Mode
Text Size
Log in / Sign up

Otoconial repositioning alters brain connectivity in benign paroxysmal positional vertigo patients.

Otoconial repositioning alters brain connectivity in benign paroxysmal positional vertigo patients.
Photo by Aakash Dhage / Unsplash
Key Takeaway
Note that otoconial repositioning increases brain connectivity in BPPV but values do not fully normalize within 7 days.

This cohort study examined patients with benign paroxysmal positional vertigo (BPPV) and healthy controls. The population consisted of 29 BPPV patients and 29 healthy controls. The intervention involved otoconial repositioning treatment, with healthy controls and pre-treatment baseline serving as comparators. The primary outcomes assessed were whole-brain functional connectivity (FC) and Dizziness Handicap Inventory (DHI) scores, with follow-up conducted 7 days after repositioning.

Before treatment, whole-brain FC was significantly lower in the BPPV group compared to the control group. The absolute values were 0.52 ± 0.20 for the BPPV group and 0.64 ± 0.18 for the control group, with a t-statistic of -4.32 and a P value less than 0.01. Following repositioning, FC in the visual cortex (V1, V2, V3) and somatosensory cortex increased relative to pre-treatment levels (P < 0.05). However, these values did not return to normal levels when compared to the control group (P < 0.05).

A negative correlation was observed between DHI scores and whole-brain FC (r = -0.62; P < 0.01). Safety data, including adverse events and tolerability, were not reported. The study findings support the development of neuroregulation-assisted therapy but are limited by the observational cohort design and lack of reported funding or conflicts of interest.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
ObjectiveTo explore the changes in brain network functional connectivity (FC) in patients with benign paroxysmal positional vertigo (BPPV) before and after otoconial repositioning treatment, and to analyze the correlation between FC and the Dizziness Handicap Inventory (DHI) score, thereby elucidating the neural basis of BPPV from a central mechanism perspective.MethodsA prospective cohort design was adopted, including 29 BPPV patients (BPPV group) and 29 healthy controls (control group). Resting-state brain network data were collected using 44-channel functional near-infrared spectroscopy (fNIRS), and the FC intensity of the whole brain and regions of interest (ROIs) was calculated. FC detection and DHI scoring were performed in the BPPV group before and 7 days after repositioning. Group comparisons were conducted using t-tests or Mann-Whitney U tests, and correlations were analyzed using Pearson analysis.ResultsThe whole-brain FC in the BPPV group before repositioning (0.52 ± 0.20) was significantly lower than that in the control group (0.64 ± 0.18) (t = −4.32, P < 0.01). Seven days after repositioning, the FC of the visual cortex V1, V2 + V3, and somatosensory cortex increased compared with that before treatment (P < 0.05), but did not return to normal levels (P < 0.05). The DHI score was negatively correlated with whole-brain FC (r = −0.62, P < 0.01).ConclusionfNIRS revealed characteristic FC alterations in BPPV: acute-phase decreases, partial sensory cortex recovery post-repositioning, and delayed prefrontal recovery. FC correlated negatively with symptom severity, suggesting its potential as an objective biomarker. These findings provide insights into central mechanisms and support neuroregulation-assisted therapy development.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.